- Home
- ACTU vs CGO Comparison
ACTU vs CGO Comparison
Compare ACTU & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- CGO
- Stock Information
- Founded
- ACTU 2015
- CGO 2004
- Country
- ACTU United States
- CGO United States
- Employees
- ACTU N/A
- CGO N/A
- Industry
- ACTU
- CGO Investment Managers
- Sector
- ACTU
- CGO Finance
- Exchange
- ACTU NYSE
- CGO Nasdaq
- Market Cap
- ACTU 135.0M
- CGO 114.2M
- IPO Year
- ACTU 2024
- CGO N/A
- Fundamental
- Price
- ACTU $7.26
- CGO $11.75
- Analyst Decision
- ACTU Strong Buy
- CGO
- Analyst Count
- ACTU 1
- CGO 0
- Target Price
- ACTU $20.00
- CGO N/A
- AVG Volume (30 Days)
- ACTU 170.2K
- CGO 34.7K
- Earning Date
- ACTU 09-23-2025
- CGO 01-01-0001
- Dividend Yield
- ACTU N/A
- CGO 9.25%
- EPS Growth
- ACTU N/A
- CGO N/A
- EPS
- ACTU N/A
- CGO N/A
- Revenue
- ACTU N/A
- CGO N/A
- Revenue This Year
- ACTU N/A
- CGO N/A
- Revenue Next Year
- ACTU N/A
- CGO N/A
- P/E Ratio
- ACTU N/A
- CGO N/A
- Revenue Growth
- ACTU N/A
- CGO N/A
- 52 Week Low
- ACTU $5.47
- CGO $7.90
- 52 Week High
- ACTU $11.99
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- CGO 61.55
- Support Level
- ACTU N/A
- CGO $11.51
- Resistance Level
- ACTU N/A
- CGO $11.77
- Average True Range (ATR)
- ACTU 0.00
- CGO 0.16
- MACD
- ACTU 0.00
- CGO -0.02
- Stochastic Oscillator
- ACTU 0.00
- CGO 86.27
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.